EUVIMEDEUVIMED entdecken
Open Access

PTEN restoration and CXCR2 depletion synergistically enhance the effect of enzalutamide and inhibit bone metastatic CRPC

Jiyuan Chen, Luyao Gong, Simeng Cao, Guanshan Song, Yeheng Peng, Yuanyuan Wang, Yan-Ru Lou, Teemu J Murtola, Yao Wu, Ganjun Yu, Yuan Gao

Theranostics · 2025

DOI: 10.7150/thno.114534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Jiyuan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Bone Neoplasms, Phenylthiohydantoin, Receptors, Interleukin-8B. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseBone NeoplasmsPhenylthiohydantoinReceptors, Interleukin-8BProstatic Neoplasms, Castration-ResistantMaleAnimalsBenzamidesHumansNitrilesMiceCell Line, TumorCyclamsRNA, Small InterferingDrug Resistance, NeoplasmDiphosphonatesXenograft Model Antitumor Assays

Stichwörter der Autor:innen

bone metastatic CRPCbone-targetingenzalutamidelipid nanoparticlesnucleic acid delivery

Substanzen

PTEN PhosphohydrolaseBenzamidesenzalutamidePhenylthiohydantoinNitrilesReceptors, Interleukin-8BPTEN protein, humanCyclamsRNA, Small InterferingDiphosphonates

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
  • Department of Pharmacy, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai 200011, China.
  • Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai 200032, China.
  • TAYS Cancer Center, Department of Urology, Tampere University Hospital, Tampere 33100, Finland.
  • National Key Laboratory of Immunity and Inflammation & Institute of Immunology, College of Basic Medical Sciences, Naval Medical University, Shanghai 200433, China.
  • State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, China.

Zitieren

APA

Chen, J., Gong, L., Cao, S., Song, G., Peng, Y., Wang, Y., Lou, Y. R., Murtola, T. J., Wu, Y., Yu, G., & Gao, Y. (2025). PTEN restoration and CXCR2 depletion synergistically enhance the effect of enzalutamide and inhibit bone metastatic CRPC. Theranostics. https://doi.org/10.7150/thno.114534

Vancouver

Chen J, Gong L, Cao S, Song G, Peng Y, Wang Y, et al. PTEN restoration and CXCR2 depletion synergistically enhance the effect of enzalutamide and inhibit bone metastatic CRPC. Theranostics. 2025. doi:10.7150/thno.114534

BibTeX
@article{Chen2025,
  author = {Chen, Jiyuan and Gong, Luyao and Cao, Simeng and Song, Guanshan and Peng, Yeheng and Wang, Yuanyuan and Lou, Yan-Ru and Murtola, Teemu J and Wu, Yao and Yu, Ganjun and Gao, Yuan},
  title = {PTEN restoration and CXCR2 depletion synergistically enhance the effect of enzalutamide and inhibit bone metastatic CRPC},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.114534}
}
Kostenlos starten →